Comparison of RT-qPCR results of different gene targets for SARS-CoV-2 in asymptomatic individuals during COVID-19 pandemic
References
- YR, G., et al., the origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Military Medical Research, 2020. 7(1).
- D, C. and V. M, WHO Declares COVID-19 a Pandemic. Acta bio-medica : Atenei Parmensis, 2020. 91(1).
- Hui, D.S., et al., the continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis, 2020. 91: p. 264-6.
- N, C., et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England), 2020. 395(10223).
- Z, H., et al., Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Science China. Life sciences, 2020. 63(5).
- H, N., et al., Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020. 94.
- Long, Q.-X., et al., Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nature Medicine, 2020. 26(8): p. 1200-1204.
- Lotfi, M., M.R. Hamblin, and N. Rezaei, COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta, 2020. 508: p. 254-6.
- E, P., et al., Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. The Lancet. Infectious diseases, 2020. 20(9).
- TT, Z. and W. FX, Primary stratification and identification of suspected Corona virus disease 2019 (COVID-19) from clinical perspective by a simple scoring proposal. Military Medical Research, 2020. 7(1).
- Zhai, P., et al., the epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents, 2020. 5(5): p. 105955.
- A, P. and J. DB, Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020. MMWR. Morbidity and mortality weekly report, 2020. 69(5).
- DKW, C., et al., Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia. Clinical chemistry, 2020. 6(4).
- LeBlanc, J.J., et al., Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories. J Clin Virol, 2020. 128: p. 104433.
- N, S., et al., Current situation of COVID-19 in northern Cyprus. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2020. 26(6).
- Sarıgul, F., et al., Investigation of Compatibility of SARS-CoV-2 RT-PCR Kits Containing Different Gene Targets During COVID-19 Pandemic. medRxiv preprint DOI: https://doi.org/10.1101/2020.06.17.20133967 , 2020.
- World Health Organization. Novel Coronavirus (2019-nCoV) situation reports. 2020.
- DM, W. and S. TP, Sequence variation in primer targets affects the accuracy of viral quantitative PCR. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2005. 34(2).
- KA, K. and C. P, Presence of mismatches between diagnostic PCR assays and coronavirus SARS-CoV-2 genome. Royal Society open science, 2020. 7(6).
- Vogels, C.B.F., et al., Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT–qPCR primer–probe sets. Nature Microbiology, 2020: p. 1-7.
DOI: https://doi.org/10.2478/ebtj-2021-0018 | Journal eISSN: 2564-615X
Language: English
Page range: 26 - 31
Published on: Jul 24, 2021
Published by: European Biotechnology Thematic Network Association
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2021 Gulten Tuncel, Mahmut Cerkez Ergoren, Buket Baddal, Pinar Tulay, Ayse Arikan, Emrah Guler, Cenk Serhan Ozverel, H. Kaya Suer, Murat Sayan, Tamer Sanlidag, published by European Biotechnology Thematic Network Association
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.